Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (atsiveria naujas langas)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Šaltinis‎: Cancer 2013;119(21):3784-7.

Kodas‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (atsiveria naujas langas)

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. (atsiveria naujas langas)

Avvisati G, ten Cate JW, Büller HR, Mandelli F.

Šaltinis‎: Lancet 1989;334(8655):122-4.

Kodas‎: PubMed 2567893

https://www.ncbi.nlm.nih.gov/pubmed/2567893 (atsiveria naujas langas)

Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions. (atsiveria naujas langas)

Ben-Bassat I, Douer D, Ramot B.

Šaltinis‎: Eur J Haematol 1990;45(2):86-9.

Kodas‎: PubMed 2209824

https://www.ncbi.nlm.nih.gov/pubmed/2209824 (atsiveria naujas langas)

Fibrinolytic inhibitors for cancer-associated bleeding problems. (atsiveria naujas langas)

Dean A, Tuffin P.

Šaltinis‎: J Pain Symptom Manage 1997;13(1):20-4.

Kodas‎: PubMed 9029858

https://www.ncbi.nlm.nih.gov/pubmed/9029858 (atsiveria naujas langas)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (atsiveria naujas langas)

Ford PA, Grant SJ, Mick R, Keck G.

Šaltinis‎: J Clin Oncol 2015;33(15):1674-9.

Kodas‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (atsiveria naujas langas)

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients. (atsiveria naujas langas)

Garewal HS, Durie BG.

Šaltinis‎: Scand J Haematol 1985;35(5):497-500.

Kodas‎: PubMed 4089529

https://www.ncbi.nlm.nih.gov/pubmed/4089529 (atsiveria naujas langas)

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. (atsiveria naujas langas)

Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M.

Šaltinis‎: Cancer 2006;107(1):136-40.

Kodas‎: PubMed 16708357

DOI‎: 10.1002/cncr.21958

https://www.ncbi.nlm.nih.gov/pubmed/16708357 (atsiveria naujas langas)

Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. (atsiveria naujas langas)

Marshall A, Li A, Drucker A, Dzik W.

Šaltinis‎: Hematol Oncol 2016;34(3):147-53.

Kodas‎: PubMed 25641349

DOI‎: 10.1002/hon.2189

https://www.ncbi.nlm.nih.gov/pubmed/25641349 (atsiveria naujas langas)

Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. (atsiveria naujas langas)

Prokopchuk-Gauk O, Brose K.

Šaltinis‎: Cureus 2015;7(12):e428.

Kodas‎: PubMed 26848417

DOI‎: 10.7759/cureus.428

https://www.ncbi.nlm.nih.gov/pubmed/26848417 (atsiveria naujas langas)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (atsiveria naujas langas)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Šaltinis‎: Leuk Lymphoma 1995;19(1-2):141-4.

Kodas‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (atsiveria naujas langas)

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. (atsiveria naujas langas)

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E.

Šaltinis‎: Hematol Oncol 2008;26(4):241-6.

Kodas‎: PubMed 18613223

DOI‎: 10.1002/hon.867

https://www.ncbi.nlm.nih.gov/pubmed/18613223 (atsiveria naujas langas)

Use of Novoseven for arsenic trioxide-induced bleeding in PML. (atsiveria naujas langas)

Alimoghaddam K, Ghavamzadeh A, Jahani M.

Šaltinis‎: Am J Hematol 2006;81(9):720.

Kodas‎: PubMed 16804937

DOI‎: 10.1002/ajh.20713

https://www.ncbi.nlm.nih.gov/pubmed/16804937 (atsiveria naujas langas)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (atsiveria naujas langas)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Šaltinis‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Kodas‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (atsiveria naujas langas)

The off-label use of recombinant FVIIa in the treatment of a patient with T-cell non-Hodgkin lymphoma who developed intra-abdominal and intra-pleural hemorrhages followed by high-dose methotreaxate therapy. (atsiveria naujas langas)

Erduran E, Bahadir A, Mutlu M.

Šaltinis‎: Eur J Clin Med Oncol 2011;3(5):1-4.

Kodas‎: EMBASE 2012295551

https://www.worldcat.org/title/european-journal-of-clinical-medical-oncology/oclc/645421559&referer=brief_results (atsiveria naujas langas)

The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review. (atsiveria naujas langas)

Franchini M, Veneri D, Lippi G.

Šaltinis‎: Bone Marrow Transplant 2007;39(12):729-35.

Kodas‎: PubMed 17417659

DOI‎: 10.1038/sj.bmt.1705670

https://www.ncbi.nlm.nih.gov/pubmed/17417659 (atsiveria naujas langas)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (atsiveria naujas langas)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Šaltinis‎: Am J Hematol 2002;69(3):219-22.

Kodas‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (atsiveria naujas langas)

Use of recombinant activated factor VII in a Jehovah's Witness patient. (atsiveria naujas langas)

Hsieh A, Cheong I.

Šaltinis‎: Am J Emerg Med 2007;25(9):1085.e1-2.

Kodas‎: PubMed 18022514

DOI‎: 10.1016/j.ajem.2007.03.007

https://www.ncbi.nlm.nih.gov/pubmed/18022514 (atsiveria naujas langas)

Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. (atsiveria naujas langas)

Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U.

Šaltinis‎: Haemostasis 1996;26 Suppl 1:159-64.

Kodas‎: PubMed 8904193

https://www.ncbi.nlm.nih.gov/pubmed/8904193 (atsiveria naujas langas)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (atsiveria naujas langas)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Šaltinis‎: Med Oncol 2010;27(1):16-9.

Kodas‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (atsiveria naujas langas)

Recombinant factor VIIa for bleeding in refractory thrombocytopenia. (atsiveria naujas langas)

Vidarsson B, Önundarson PT.

Šaltinis‎: Thromb Haemost 2000;83(4):634-5.

Kodas‎: PubMed 10780334

https://www.ncbi.nlm.nih.gov/pubmed/10780334 (atsiveria naujas langas)

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. (atsiveria naujas langas)

Zver S, Andoljšek D, Černelč P.

Šaltinis‎: Eur J Haematol 2004;72(6):455-6.

Kodas‎: PubMed 15128428

DOI‎: 10.1111/j.1600-0609.2004.00237.x

https://www.ncbi.nlm.nih.gov/pubmed/15128428 (atsiveria naujas langas)

Management of bleeding complications of hematologic malignancies. (atsiveria naujas langas)

Green D.

Šaltinis‎: Semin Thromb Hemost 2007;33(4):427-34.

Kodas‎: PubMed 17525900

DOI‎: 10.1055/s-2007-976178

https://www.ncbi.nlm.nih.gov/pubmed/17525900 (atsiveria naujas langas)

Vitamin K deficiency in cancer patients referred to a hospital palliative care team with bleeding and the impact of vitamin K replacement on laboratory indicators of vitamin K status. (atsiveria naujas langas)

Harrington DJ, Booth L, Dando N, Cottingham L, Beynon T.

Šaltinis‎: Int J Lab Hematol 2013;35(4):457-9.

Kodas‎: PubMed 23216984

DOI‎: 10.1111/ijlh.12035

https://www.ncbi.nlm.nih.gov/pubmed/23216984 (atsiveria naujas langas)

Management of bleeding in patients with advanced cancer. (atsiveria naujas langas)

Pereira J, Phan T.

Šaltinis‎: Oncologist 2004;9(5):561-70.

Kodas‎: PubMed 15477642

DOI‎: 10.1634/theoncologist.9-5-561

https://www.ncbi.nlm.nih.gov/pubmed/15477642 (atsiveria naujas langas)

Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. (atsiveria naujas langas)

Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F.

Šaltinis‎: Haematologica 1997;82(5):584-7.

Kodas‎: PubMed 9407726

https://www.ncbi.nlm.nih.gov/pubmed/9407726 (atsiveria naujas langas)

Desmopressin and other synthetic vasopressin analogues in cancer treatment. (atsiveria naujas langas)

Gomez DE, Ripoll GV, Girón S, Alonso DF.

Šaltinis‎: Bull Cancer 2006;93(2):E7-12.

Kodas‎: PubMed 16517412

https://www.ncbi.nlm.nih.gov/pubmed/16517412 (atsiveria naujas langas)